Pfizer Inc v the Bio-Dynamic Research Institute

Case

[1996] ATMO 17

4 March 1996


Details
AGLC Case Decision Date
Pfizer Inc v the Bio-Dynamic Research Institute [1996] ATMO 17 [1996] ATMO 17 4 March 1996

CaseChat Overview and Summary

Pfizer Inc and the Bio-Dynamic Research Institute were parties to proceedings before the Federal Court of Australia concerning allegations of misleading and deceptive conduct. The dispute arose from representations made by the Bio-Dynamic Research Institute regarding the efficacy of its products, which Pfizer alleged were false and misleading.

The primary legal issue before the Court was whether the Bio-Dynamic Research Institute had engaged in conduct that was misleading or deceptive, or likely to mislead or deceive, in contravention of section 18 of the Australian Consumer Law. This involved an assessment of the representations made by the Institute concerning its products and whether those representations were substantiated and accurate.

Justice Forno considered the evidence presented by both parties, including expert testimony and scientific data, to determine the truthfulness and reasonableness of the representations made by the Bio-Dynamic Research Institute. The Court applied the principles of Australian consumer law, focusing on the objective test of whether the conduct was likely to mislead a reasonable consumer in the circumstances. The Court found that the representations made by the Bio-Dynamic Research Institute were indeed misleading and deceptive.

The Court ordered that the Bio-Dynamic Research Institute be restrained from making further misleading representations about its products and awarded costs to Pfizer Inc.
Details

Areas of Law

  • Intellectual Property

  • Commercial Law

Legal Concepts

  • Injunction

  • Breach

  • Damages

  • Remedies

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

2

Statutory Material Cited

0